Cyanotech Corporation (CYAN)
- Previous Close
0.3005 - Open
0.3000 - Bid --
- Ask --
- Day's Range
0.3005 - 0.3005 - 52 Week Range
0.1200 - 1.1600 - Volume
16 - Avg. Volume
24,809 - Market Cap (intraday)
2.069M - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7300 - Earnings Date Jun 25, 2024 - Jul 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. The company was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
www.cyanotech.comRecent News: CYAN
Performance Overview: CYAN
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CYAN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CYAN
Valuation Measures
Market Cap
2.07M
Enterprise Value
12.62M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.09
Price/Book (mrq)
0.15
Enterprise Value/Revenue
0.56
Enterprise Value/EBITDA
-6.85
Financial Highlights
Profitability and Income Statement
Profit Margin
-20.52%
Return on Assets (ttm)
-8.51%
Return on Equity (ttm)
-29.25%
Revenue (ttm)
22.49M
Net Income Avi to Common (ttm)
-4.62M
Diluted EPS (ttm)
-0.7300
Balance Sheet and Cash Flow
Total Cash (mrq)
661k
Total Debt/Equity (mrq)
81.03%
Levered Free Cash Flow (ttm)
1.68M